Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Patients saved as much as $222 per telehealth visit during the COVID pandemic.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
However, Black people and uninsured folks with cancer were not as likely to access care via telemedicine.
People diagnosed with cancer over a year ago and those who were not on treatment did not have a higher risk of hospitalization or death.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
But cancer survivors are actually less likely to believe COVID-19 misinformation than everyone else.
However, the study data were collected before booster vaccines were recommended for people with cancer.
Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.
People with blood cancers and those on chemotherapy may not respond adequately to their first two vaccine doses.
Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.
The booster is recommended for organ transplant recipients, people receiving cancer treatment and people with advanced or untreated HIV.
Some people with blood cancers, however, may not be as well protected.
People with both cancer and COVID-19 frequently report gastrointestinal symptoms, such as nausea and diarrhea.
Vaccines that stimulate immune responses against cancer using the mRNA technology may be fast-acting and cheap to make.
The report highlights how cancer research is extending and improving lives and includes a special feature on COVID-19 and cancer challenges.
Recent studies suggest chemotherapy and immunotherapy are not linked to more severe COVID-19.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.